##gff-version 3
##sequence-region Q15831 1 433
Q15831	UniProtKB	Chain	1	430	.	.	.	ID=PRO_0000086699;Note=Serine/threonine-protein kinase STK11	
Q15831	UniProtKB	Propeptide	431	433	.	.	.	ID=PRO_0000422300;Note=Removed in mature form;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q15831	UniProtKB	Domain	49	309	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q15831	UniProtKB	Nucleotide binding	55	63	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q15831	UniProtKB	Region	45	90	.	.	.	Note=Sufficient for interaction with SIRT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Active site	176	176	.	.	.	Note=Proton acceptor	
Q15831	UniProtKB	Binding site	78	78	.	.	.	Note=ATP;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q15831	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q15831	UniProtKB	Modified residue	44	44	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Modified residue	48	48	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Modified residue	96	96	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Modified residue	97	97	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Modified residue	189	189	.	.	.	Note=Phosphothreonine%3B by autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11430832;Dbxref=PMID:11430832	
Q15831	UniProtKB	Modified residue	296	296	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Modified residue	311	311	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Modified residue	325	325	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9WTK7	
Q15831	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphothreonine%3B by autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12805220;Dbxref=PMID:12805220	
Q15831	UniProtKB	Modified residue	363	363	.	.	.	Note=Phosphothreonine%3B by ATM and autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12805220;Dbxref=PMID:12805220	
Q15831	UniProtKB	Modified residue	401	401	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q15831	UniProtKB	Modified residue	416	416	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Modified residue	423	423	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Modified residue	428	428	.	.	.	Note=Phosphoserine%3B by autocatalysis%2C PKA%2C PKC/PRKCZ and RPS6KA1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18321849,ECO:0000269|PubMed:18854309;Dbxref=PMID:18321849,PMID:18854309	
Q15831	UniProtKB	Modified residue	430	430	.	.	.	Note=Cysteine methyl ester;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q15831	UniProtKB	Modified residue	431	431	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Lipidation	418	418	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q15831	UniProtKB	Lipidation	430	430	.	.	.	Note=S-farnesyl cysteine;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q15831	UniProtKB	Alternative sequence	371	433	.	.	.	ID=VSP_041746;Note=In isoform 2. QVPEEEASHNGQRRGLPKAVCMNGTEAAQLSTKSRAEGRAPNPARKACSASSKIRRLSACKQQ->GEEASEAGLRAERGLQKSEGSDLSGEEASRPAPQ;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q15831	UniProtKB	Natural variant	14	14	.	.	.	ID=VAR_065627;Note=In cervical cancer%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12533684;Dbxref=PMID:12533684	
Q15831	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_065628;Note=In PJS. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21411391;Dbxref=PMID:21411391	
Q15831	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_033138;Note=In melanoma%3B sporadic malignant%3B somatic mutation. Y->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10201537;Dbxref=dbSNP:rs137853080,PMID:10201537	
Q15831	UniProtKB	Natural variant	50	53	.	.	.	ID=VAR_071057;Note=In PJS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9837816;Dbxref=PMID:9837816	
Q15831	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_065629;Note=In cervical carcinoma%3B somatic mutation. V->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12533684,ECO:0000269|PubMed:19892943;Dbxref=PMID:12533684,PMID:19892943	
Q15831	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_006202;Note=In PJS%3B abolishes kinase activity%2C leading to loss of autophosphorylation. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9428765,ECO:0000269|PubMed:9837816;Dbxref=dbSNP:rs137853077,PMID:9428765,PMID:9837816	
Q15831	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_065630;Note=In sporadic cancer%3B somatic mutation%3B no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=dbSNP:rs1057520039,PMID:19892943	
Q15831	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_041139;Note=In a metastatic melanoma sample%3B somatic mutation. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q15831	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_065631;Note=In sporadic cancer%3B somatic mutation%3B no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39. Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=dbSNP:rs764449808,PMID:19892943	
Q15831	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_033139;Note=In melanoma%3B sporadic malignant%3B somatic mutation. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10201537;Dbxref=dbSNP:rs137853081,PMID:10201537	
Q15831	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_065632;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_065633;Note=In cervical cancer%3B somatic mutation. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12533684;Dbxref=PMID:12533684	
Q15831	UniProtKB	Natural variant	162	164	.	.	.	ID=VAR_007920;Note=In PJS. DGL->NDM	
Q15831	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_033140;Note=In TGCT%3B a tumor with seminoma and teratoma components%3B associated with severely impaired but detectable kinase activity%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39%3B predominantly nuclear localization. G->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19892943,ECO:0000269|PubMed:9605748,ECO:0000269|PubMed:9887330;Dbxref=dbSNP:rs137853078,PMID:19892943,PMID:9605748,PMID:9887330	
Q15831	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_065634;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. Q->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_065635;Note=In colorectal cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19892943,ECO:0000269|PubMed:9731485;Dbxref=PMID:19892943,PMID:9731485	
Q15831	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_065636;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_071058;Note=In PJS%3B loss of kinase activity%2C leading to greatly reduced autophosphorylation%3B fails to phosphorylate PTEN in vitro%3B no significant effect on nucleocytoplasmic localization. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15987703,ECO:0000269|PubMed:9837816;Dbxref=dbSNP:rs730881979,PMID:15987703,PMID:9837816	
Q15831	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_065637;Note=In sporadic cancer%3B somatic mutation%3B Loss of kinase activity. D->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12805220,ECO:0000269|PubMed:19892943;Dbxref=PMID:12805220,PMID:19892943	
Q15831	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_065638;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=dbSNP:rs1057520041,PMID:19892943	
Q15831	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_065639;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39%3B requires 2 nucleotide substitutions. N->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_007921;Note=In PJS. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10408777;Dbxref=dbSNP:rs121913315,PMID:10408777	
Q15831	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_065640;Note=In lung cancer%3B somatic mutation. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10079245;Dbxref=dbSNP:rs121913316,PMID:10079245	
Q15831	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_033141;Note=In melanoma%3B sporadic malignant%3B somatic mutation. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10208439;Dbxref=dbSNP:rs121913315,PMID:10208439	
Q15831	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_065641;Note=In colorectal cancer%3B somatic mutation%3B impaired kinase activity. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9731485;Dbxref=dbSNP:rs121913317,PMID:9731485	
Q15831	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_065642;Note=In sporadic cancer%3B somatic mutation%3B does not affect kinase activity. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_065643;Note=In sporadic cancer%3B somatic mutation%3B no effect heterotrimeric complex assembly with STRADA and CAB39. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=dbSNP:rs730881981,PMID:19892943	
Q15831	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_065644;Note=In colorectal cancer%3B somatic mutation%3B no effect heterotrimeric complex assembly with STRADA and CAB39. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9731485;Dbxref=PMID:9731485	
Q15831	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_065645;Note=In colorectal cancer%3B somatic mutation. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9731485;Dbxref=dbSNP:rs1057520038,PMID:9731485	
Q15831	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_065646;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=dbSNP:rs1057520017,PMID:19892943	
Q15831	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_065647;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_065648;Note=In sporadic cancer%3B somatic mutation%3B no effect heterotrimeric complex assembly with STRADA and CAB39. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_065649;Note=In cervical cancer%3B somatic mutation. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12533684;Dbxref=dbSNP:rs929783669,PMID:12533684	
Q15831	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_065650;Note=In sporadic cancer%3B somatic mutation%3B no effect heterotrimeric complex assembly with STRADA and CAB39. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_033142;Note=In PJS%3B late onset suggests reduced penetrance. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12372054;Dbxref=dbSNP:rs137853082,PMID:12372054	
Q15831	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_065651;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_006203;Note=In PJS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9760200;Dbxref=PMID:9760200	
Q15831	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_065652;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_065653;Note=In sporadic cancer%3B somatic mutation%3B no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_065654;Note=In sporadic cancer%3B somatic mutation%3B no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_065655;Note=In ovarian carcinoma%3B somatic mutation. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10429654;Dbxref=dbSNP:rs121913322,PMID:10429654	
Q15831	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_065656;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39. L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_007922;Note=In PJS. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10408777;Dbxref=PMID:10408777	
Q15831	UniProtKB	Natural variant	303	306	.	.	.	ID=VAR_033143;Note=In PJS. IRQH->N	
Q15831	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_071059;Note=In PJS%3B abolishes kinase activity%2C leading to loss of autophosphorylation. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9837816;Dbxref=dbSNP:rs1057520042,PMID:9837816	
Q15831	UniProtKB	Natural variant	314	314	.	.	.	ID=VAR_065657;Note=In colorectal cancer%3B no effect heterotrimeric complex assembly with STRADA and CAB39. P->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9809980;Dbxref=PMID:9809980	
Q15831	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_033144;Note=In PJS%3B pathogenicity uncertain%3B no effect heterotrimeric complex assembly with STRADA and CAB39. P->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12372054,ECO:0000269|PubMed:19892943;Dbxref=dbSNP:rs786202431,PMID:12372054,PMID:19892943	
Q15831	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_065658;Note=In gastric carcinoma%3B no effect heterotrimeric complex assembly with STRADA and CAB39. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9683800;Dbxref=dbSNP:rs367807476,PMID:9683800	
Q15831	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_065659;Note=In colorectal cancer%3B somatic mutation. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9731485;Dbxref=dbSNP:rs59912467,PMID:9731485	
Q15831	UniProtKB	Natural variant	367	367	.	.	.	ID=VAR_065660;Note=In colorectal cancer%3B somatic mutation. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9731485;Dbxref=dbSNP:rs587782835,PMID:9731485	
Q15831	UniProtKB	Mutagenesis	44	44	.	.	.	Note=No effect on kinase activity. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Mutagenesis	48	48	.	.	.	Note=No effect on basal nucleocytoplasmic localization%2C but fails to translocate to the cytoplasm when coexpressed with SIRT1. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Enhanced phosphorylation at Thr-336 and Ser-428%2C enhanced cytoplasmic localization and increased kinase activity. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Impaired formation of a heterotrimeric complex with STRADA and CAB39%3B when associated with A-204. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Loss of kinase activity%2C leading to greatly reduced autophosphorylation. K->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11430832,ECO:0000269|PubMed:9837816;Dbxref=PMID:11430832,PMID:9837816	
Q15831	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Loss of kinase activity%2C leading to reduced autophosphorylation and acting as a dominant-negative mutant. K->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11430832,ECO:0000269|PubMed:9837816;Dbxref=PMID:11430832,PMID:9837816	
Q15831	UniProtKB	Mutagenesis	96	96	.	.	.	Note=No effect on kinase activity. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Mutagenesis	97	97	.	.	.	Note=No effect on kinase activity. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18687677;Dbxref=PMID:18687677	
Q15831	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Reduced phosphorylation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11430832;Dbxref=PMID:11430832	
Q15831	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Loss of kinase activity. D->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14517248,ECO:0000269|PubMed:14976552,ECO:0000269|PubMed:19892943;Dbxref=PMID:14517248,PMID:14976552,PMID:19892943	
Q15831	UniProtKB	Mutagenesis	204	204	.	.	.	Note=No effect. Impaired formation of a heterotrimeric complex with STRADA and CAB39%3B when associated with A-74. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19892943;Dbxref=PMID:19892943	
Q15831	UniProtKB	Mutagenesis	428	428	.	.	.	Note=No effect on kinase activity. S->A%2CE;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18321849,ECO:0000269|PubMed:18854309;Dbxref=PMID:18321849,PMID:18854309	
Q15831	UniProtKB	Mutagenesis	428	428	.	.	.	Note=Inhibits peroxynitrite-induced nuclear export of STK11%2C and consequent PTEN phosphorylation and inhibition of PI3K/Akt signaling. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18321849,ECO:0000269|PubMed:18854309;Dbxref=PMID:18321849,PMID:18854309	
Q15831	UniProtKB	Beta strand	54	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	62	68	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Turn	69	71	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	74	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	82	87	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	91	102	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	113	118	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	125	130	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	133	135	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	136	142	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	150	169	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	179	181	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	182	184	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	190	192	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	217	219	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	222	225	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	231	233	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	234	250	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	260	269	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Beta strand	276	278	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	280	289	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Turn	294	296	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	300	305	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	307	310	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
Q15831	UniProtKB	Helix	334	336	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZDR	
Q15831	UniProtKB	Helix	339	341	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2WTK	
